|
Management of adult immune thrombocytopenia: Recommendations by an expert Saudi panel
Hazzaa Al-Zahrani1, Aamer Aleem2, Fahad Al Mohareb1, Said Yousuf Ahmed3, Ahmed M Al-Suliman4, Hussain H Al Saeed5, Mubarak S Al-Ghamdi6, Hani Al-Hashmi7
1 Section of Adult Hematology and Hematopoietic Stem Cell Transplantation, Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
2 Hematology/Oncology Division, Department of Medicine, College of Medicine & King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
3 Department of Hematology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
4 Blood Disorders Center, King Fahad Hospital, Hofuf, Saudi Arabia
5 Qatif Central Hospital, Qatif, Saudi Arabia
6 Department of Internal Medicine, Hematology, and Stem Cell Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia
7 Oncology Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia
Correspondence Address:
Prof. Aamer Aleem
Department of Medicine (38), P.O. Box 7805, King Khalid University Hospital, King Saud University, Riyadh 11472
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/joah.joah_51_19
|
|
Immune thrombocytopenia (ITP) is a disorder characterized by an isolated thrombocytopenia in the absence of an identifiable cause. Management of ITP patients varies according to the clinical presentation, physicians' experience, availability of resources, and patient preferences. Currently, multiple therapeutic options are available for the management of chronic ITP and include splenectomy, rituximab, thrombopoietin-receptor agonists, and immunosuppressant agents. To develop a common approach on the management of adult ITP patients, a meeting of a panel of hematologists experienced in the management of ITP was convened. This review focuses on the expert opinion based on local experience in the field, in light of relevant literature and guidelines, and provides expert recommendations for the diagnosis and management of adult patients with ITP in Saudi Arabia. |
